 Esperion Therapeutics, Inc. NASDAQ:ESPR Q3 2022 Earnings Conference Call November 1, 2022 8:00 AM ET Company Participants Tiffany Aldrich - Associate Director, Corporate Communications Sheldon Koenig - President Chief Executive Officer JoAnne Foody - Chief Medical Officer Eric Warren - Chief Commercial Officer Benjamin Halladay - Senior Director of Finance Conference Call Participants Mike Yee - Jefferies Serge Belanger - Needham Company Tom Shrader - BTIG Mike Riad - Morgan Stanley Joseph Thome - Cowen Jason Butler - JMP Securities Judah Frommer - Credit Suisse Paul Choi - Goldman Sachs Operator Ladies and gentlemen, thank you for standing by and welcome. Operator Instructions Please be advised that todays conference call may be recorded. 